Dr. Doris A. Taylor, Ph.D. - CEO, Organamet Bio Inc. - Personalized Bio-Engineered Human Hearts For All

Send us Fan MailDr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet has a goal is to make personalized bio-engineered human hearts, available to all who need them, within 5 years, increasing availability and access to hearts, decreasing or eliminating need for immunosuppression, reducing total lifetime transplant costs, and improving quality of life. Dr. Taylor was previously the Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology, at the Texas Heart Institute in Houston, Texas, where she worked on the integration of regenerative medicine and tissue engineering. Dr. Taylor has a Ph.D. in Pharmacology from UT Southwestern Medical Center, Dallas, Texas. She did her post-doctoral studies at Albert Einstein College of Medicine in the Bronx, New York, where she first worked with tissue engineering, growing heart muscle cells in the laboratory. Dr. Taylor was on the faculty of Duke University from 1991 to 2007, and then moved to University of Minnesota, where in 2008 her team published a landmark paper in Nature Medicine where they created new beating rat hearts using a combination of tissue engineering processes, first stripping the dead dying cells away from an existing heart (in a process called "de-cellularization") leaving behind the hearts extracellular matrix and then re-seeding the matrix by injecting new young rat stem cells. Dr. Taylor is also Co-Founder and original Board member of Miromatrix Medical Inc. Dr. Taylor's work has been published in Nature Medicine, Circulation Research, The Journal of Molecular Biology, The Journal of Biochemistry, Journal of the American College of Cardiology (JACC), Journal of the American Medical Association (JAMA), and other top-tier scientific journals. She holds a number of invention disclosures, patent applications and patents and is the founder of multiple companies dedicated to cardiovascular repair technologies. She is a member of the Society for Women's Health Research (SWHR) Cardiovascular Working Group and the Organization for the Study of Sex Differences (OSSD). Other professional affiliations include the American Association for the Advancement of Science (AAAS), the American Heart Association (AHA), and the Federation of American Societies for Experimental Biology (FASEB), among others. She recently served on the Executive Committee for the Alliance for Regenerative Medicine (ARM). Dr. Taylor has been recognized by the AHA for Top 10 Research Advances. Her work has been recognized and featured by 60 Minutes, NPR, CNN, The New York Times, The Wall Street Journal, BBC Horizon, BBC News Health, ABC News, NBC News, CBS News, Associated Press, National Public Radio, Good Morning America, Forbes, the Oprah Winfrey Show, NOVA Science Now, Discovery Channel’s Through the Worm Hole with Morgan Freeman, Science Channel’s Stem Cell Universe with Stephen Hawking, and numerous other worldwide media outlets.Support the show